Product Information
Applications
Biological Information
Primary TargetCB2 receptor
Primary Target K<sub>i</sub>13.8 nM
Purity≥95% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Standard Handling
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

CB2 agonist, JWH 015 - CAS 155471-08-2 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

References

Reference overview
Aung, M., et al. 2000. Drug Alcohol Depend. 60, 133.
Murataeva, N., et al. 2012. Pharmacol. Res. 66, 437.
Marriott, K., et al. 2008. Curr Top Med Chem. 8, 187.
Ghosh, S., et al. 2006. Mol Immunol. 43, 2169.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision28-June-2013 JSW
Synonyms(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone, JWH-015, JWH 015
DescriptionA potent and highly selective agonist for cannabinoid subtye 2 (CB2) receptor. Affinity for CB2 (Ki = 13.8 nM) is more than 28-fold higher than that for CB1 (Ki = 383 nM) receptors.
FormWhite solid
CAS number155471-08-2
Chemical formulaC₂₃H₂₁NO
Structure formulaStructure formula
Purity≥95% by HPLC
SolubilityDMSO (10 mg/ml)
Storage -20°C
Protect from light
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
ReferencesAung, M., et al. 2000. Drug Alcohol Depend. 60, 133.
Murataeva, N., et al. 2012. Pharmacol. Res. 66, 437.
Marriott, K., et al. 2008. Curr Top Med Chem. 8, 187.
Ghosh, S., et al. 2006. Mol Immunol. 43, 2169.

Related Products & Applications

Categories

Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Neurochemicals > Agonists > Cannibinoid Receptor Agonists